Clinical Trials Logo

Opioid-induced Constipation clinical trials

View clinical trials related to Opioid-induced Constipation.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04930237 Withdrawn - OIC Clinical Trials

RELISTOR's Effects on Opioid-Induced Constipation

Start date: July 1, 2021
Phase:
Study type: Observational

This will be a prospective case-control study of 40 patients undergoing 1-2 level ALIF procedures at Methodist Dallas Medical Center (MDMC). Patient records will be reviewed to identify details including demographics, comorbidities, procedure details, and the primary and secondary outcome metrics.

NCT ID: NCT00858754 Withdrawn - Clinical trials for Opioid-Induced Constipation

Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects

Start date: March 2009
Phase: Phase 4
Study type: Interventional

This purpose of this study is to evaluate the safety and effectiveness of a subcutaneous (injection beneath the skin) form of methylnaltrexone in subjects who have cancer-related pain and constipation from taking opioids. The length of participation will be up to 7 weeks.